These findings suggest that ABCA1 plays a role in the proliferation and drug resistance of STAD, and if further studies are carried out, ABCA1 may also be found to be a key factor in inhibiting the spread of gastric cancer cells. This evidence concerns the gene ABCA1 and gastric adenocarcinoma.